elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35674616-CFB676C2-DB6B-491D-A649-2EED029ED4D0
Q35674616-CFB676C2-DB6B-491D-A649-2EED029ED4D0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35674616-CFB676C2-DB6B-491D-A649-2EED029ED4D0
A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52).
P577
Q35674616-CFB676C2-DB6B-491D-A649-2EED029ED4D0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35674616-CFB676C2-DB6B-491D-A649-2EED029ED4D0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
25e548b181e13e223d327163aef265957e521d1c
P577
2015-06-25T00:00:00Z
http://www.w3.org/2001/XMLSchema#dateTime
P577
4d0edadd6dfb4e887d7ab5c578bc17be